Table 4.
ER/PR/Her2 TNBC vs. non (any+) | No. (%) BRCA positive
|
Total No. of cases* | ||
---|---|---|---|---|
BRCA1 | BRCA2 | Total | ||
TNBC cases | 9 | 0 | 9 (27%) | 33 |
Non-TNBC | 2 | 3 | 5 (8%) | 62 |
All cases | 11 | 3 | 14 (15%) | 95 |
ER: estrogen receptor, PR: progesterone receptor, TNBC: triple negative breast cancer.
Excluded one case with unknown tumor receptor status.